Citryll...announces that the first patient has been successfully dosed in its imaging study, ‘Cityview’, evaluating the distribution of radiolabeled CIT-013 in participants with rheumatoid arthritis (RA) and hidradenitis suppurativa (HS).

CIT-013 - Citryll

Feb 17, 2026